CNTA
Centessa Pharmaceuticals plc
NASDAQ · Healthcare · Biotechnology · GB
$40.50
+0.00%Sep 3, 2026, 07:10 UTC
Nexera Pharma announced it will receive a milestone payment of $8.6 million from Centessa Pharmaceuticals, a subsidiary of Eli Lilly, due to progress in late-stage development of an OX2R agonist.
Jul 8, 2026, 07:55 UTC
Eli Lilly acquired Centessa Pharmaceuticals for $7.8 billion.
Source:Jun 24, 2026, 12:45 UTC
Eli Lilly completed its acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders.
Source:Jun 22, 2026, 20:05 UTC
The High Court of Justice of England and Wales approved the acquisition of Centessa Pharmaceuticals by Eli Lilly and Company for $38.00 per share plus a contingent value right, totaling approximately $7.8 billion.
Source: